Bayer AG
BAYRY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.56 | 0.07 | 0.04 | -0.43 |
| FCF Yield | 24.79% | 7.09% | 8.78% | 5.41% |
| EV / EBITDA | 6.02 | 17.16 | 8.01 | 11.59 |
| Quality | ||||
| ROIC | 4.17% | -0.27% | 5.72% | 3.71% |
| Gross Margin | 54.36% | 58.54% | 60.84% | 61.85% |
| Cash Conversion Ratio | -2.89 | -1.74 | 1.70 | 4.98 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.79% | 2.62% | 7.02% | 0.41% |
| Free Cash Flow Growth | 94.00% | -42.91% | 67.23% | -0.28% |
| Safety | ||||
| Net Debt / EBITDA | 3.92 | 9.24 | 3.49 | 5.02 |
| Interest Coverage | 1.41 | -0.07 | 3.37 | 5.18 |
| Efficiency | ||||
| Inventory Turnover | 1.59 | 1.42 | 1.46 | 1.49 |
| Cash Conversion Cycle | 178.48 | 191.59 | 185.35 | 180.43 |